New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 1, 2014
11:12 EDTTEVATeva price target raised to $57 from $53 at BMO Capital
BMO Capital raised its price target for Teva shares to $57 after the Supreme Court agreed to hear the company's appeal in its case against Momenta (MNTA), Novartis (NVS) and Mylan (MYL). BMO thinks Copaxone generics will not meaningfully affect 2014 and keeps an Outperform rating on the stock.
News For TEVA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 29, 2014
07:19 EDTTEVAUBS to hold a field trip
Subscribe for More Information
05:26 EDTTEVAProtalix appoints Moshe Manor as CEO
Subscribe for More Information
September 17, 2014
11:01 EDTTEVAActavis drops after NY AG seeks to block Alzheimer drug switch
Subscribe for More Information
08:05 EDTTEVAEagle Pharm says Teva requests motion to dismiss Bendamustine lawsuit
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use